2009
DOI: 10.1016/j.ijrobp.2008.07.042
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Dosimetric Parameters and Disease Response After 125Iodine Transperineal Brachytherapy for Low- and Intermediate-Risk Prostate Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
33
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
5
4
1

Relationship

4
6

Authors

Journals

citations
Cited by 57 publications
(36 citation statements)
references
References 21 publications
3
33
0
Order By: Relevance
“…Our implant procedure has been previously described in detail (3,10). In brief, radioactive seeds are implanted using a preplanned, ultrasound (US)-guided transperineal technique described by the Seattle group.…”
Section: Treatment Planning and Philosophymentioning
confidence: 99%
“…Our implant procedure has been previously described in detail (3,10). In brief, radioactive seeds are implanted using a preplanned, ultrasound (US)-guided transperineal technique described by the Seattle group.…”
Section: Treatment Planning and Philosophymentioning
confidence: 99%
“…As of March 2009, more than 2,500 men have been treated with 125 I monotherapy. In previous reports, our group has provided detailed oncologic outcomes for a cohort consisting of the first of 1,006 consecutive brachytherapy patients (18,19). In those reports, 57 men were identified whose PSA profile triggered the nadir PSA + 2 ng/mL À1 definition.…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies have confirmed D 90 (the minimum dose received by 90% of the prostate volume) and V 100 (percentage of the prostate volume receiving 100% of the prescribed dose) are correlated with outcome [54][55][56].…”
Section: Dose Selectionmentioning
confidence: 99%